Evidence map›Paper›PMID 41326585›Full record

ArticleScientific reports2025

Layer by layer preparation of Fe

Solmaz Ohadian Moghadam, Lida Lotfollahi Hagghi, Reza Taghavi, Mohammad Reza Nowroozi, Ziba Karimi, Amir Hasanzadeh, Sadegh Rostamnia

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Solmaz Ohadian MoghadamUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, 14197-33141, Iran.
Lida Lotfollahi HagghiDepartment of Microbiology and Virology, School of Medicine, Urmia University of Medical Sciences, Urmia, 57157-99313, Iran.
Reza TaghaviAdvanced Porous Materials and Energy Technology (APMET) Res. Lab., Department of Chemistry, Iran University of Science and Technology (IUST), Tehran, PO Box 16846-13114, Iran.
Mohammad Reza NowrooziUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, 14197-33141, Iran.
Ziba KarimiAdvanced Porous Materials and Energy Technology (APMET) Res. Lab., Department of Chemistry, Iran University of Science and Technology (IUST), Tehran, PO Box 16846-13114, Iran.
Amir HasanzadehDepartment of Microbiology and Virology, School of Medicine, Urmia University of Medical Sciences, Urmia, 57157-99313, Iran. hasanzadeh.a@umsu.ac.ir.
Sadegh RostamniaAdvanced Porous Materials and Energy Technology (APMET) Res. Lab., Department of Chemistry, Iran University of Science and Technology (IUST), Tehran, PO Box 16846-13114, Iran. srostamnia@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To solve antimicrobial resistance in bacteria, metal nanoparticles (NPs) have gained tremendous attention due to their effectiveness and ease of use. Here, we prepared a core-shell dithiocarbonate carbon functionalized magnetic composite and employed it to support and stabilize the silver nanoparticle (Ag NPs). A chemical reduction method was employed to decorate the Ag NPs over the surface of the magnetic composite. The prepared materials were characterized using FT-IR, XRD, VSM, EDX, SEM, TEM, particle size distribution analysis, and elemental mapping. The results demonstrated that the designed support effectively prevented aggregation of the Ag NPs, ensuring their uniform dispersion throughout the structure. The Ag NPs decorated core-shell material was used as an antimicrobial agent against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus. The minimum inhibitory concentrations of nanocomposite against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus were 0.58 ± 0.38, 1 ± 0, and 4.67 ± 3.06 µg mL

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsBiofilmsMetal NanoparticlesSilverAnimalsColloidsEscherichia coliMiceMicrobial Sensitivity TestsNanocompositesNIH 3T3 CellsPseudomonas aeruginosaStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective AgentsColloidsSilverAg NPsAntibacterialAnti-biofilmDithiocarbonate functionalizationMagnetic NPs

Identifiers

PMID41326585
PMCPMC12775416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.